Prostate Cancer Trial, Recruiting NCT05183074 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT05183074
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People whose prostate cancer has been confirmed through a tissue sample (biopsy or similar test)
  • People with localised prostate cancer (cancer that has not spread beyond the prostate) that falls into certain risk categories — low-risk, intermediate-risk, or selected high-risk — based on specific test results and tumour characteristics (confirm with trial site for exact classification)
  • People with low-risk localised prostate cancer who have chosen not to pursue active surveillance (a watch-and-wait approach)
  • People with a small number of cancer spots that have spread to other parts of the body, where all affected areas can be safely treated with a focused, high-dose radiation technique called SBRT
  • People with a physical performance level rated 0, 1, or 2 on a standard medical scale, meaning they are able to carry out daily activities with little to no limitation
  • People whose prostate gland is no larger than 100cc in volume
  • People with a urinary symptom score below 18 on a standard questionnaire (meaning urinary symptoms are not severely impacting daily life)
  • People who have read, understood, and signed a consent form agreeing to take part in the study

Who may not be able to join:

  • People who are unable to have an MRI scan for medical reasons
  • People who have had a surgical procedure called TURP (a type of prostate surgery) within the past 6 months
  • People who have certain conditions including ulcerative colitis, Crohn's disease, ataxia telangiectasia, or systemic lupus erythematosus
  • People who have previously received radiation therapy to the pelvic area
  • People who are not willing to use contraception during the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +868611804268

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
1 February 2021
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The Incidence of Acute GU and GI toxicities: Number of participants with treatment-related adverse events as assessed by CTCAE v5.0

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov